Does COVID-19 cause hypertension?
M Akpek - Angiology, 2022 - journals.sagepub.com
The coronavirus disease 2019 (COVID-19) outbreak remains a major public health
challenge worldwide. The present study investigated the effect of COVID-19 on blood …
challenge worldwide. The present study investigated the effect of COVID-19 on blood …
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
A Kurdi, T Mueller, N Weir - European journal of clinical …, 2023 - Wiley Online Library
Background Despite the availability of extensive literature on the effect of angiotensin‐
converting enzyme inhibitors (ACEIs)/angiotensin‐receptor blockers (ARBs) on COVID‐19 …
converting enzyme inhibitors (ACEIs)/angiotensin‐receptor blockers (ARBs) on COVID‐19 …
[HTML][HTML] Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in …
MV Shestakova, OK Vikulova, AR Elfimova… - Frontiers in …, 2022 - frontiersin.org
The aim To study the association of demographic, clinical, and laboratory factors and the
use of glucose-lowering drugs and anti-coronavirus disease (COVID-19) vaccination with …
use of glucose-lowering drugs and anti-coronavirus disease (COVID-19) vaccination with …
[HTML][HTML] COVID-19-associated liver injury, role of drug therapy and management: a review
CO Iheanacho, OH Enechukwu - Egyptian Liver Journal, 2022 - Springer
The ongoing COVID-19 pandemic is known to affect several body organs, including the liver.
This results from several factors such as direct effect of SARS-CoV-2 on the liver, side effects …
This results from several factors such as direct effect of SARS-CoV-2 on the liver, side effects …
[HTML][HTML] Risk perception and acceptability of the COVID-19 vaccine in Nigeria
CO Iheanacho, OH Enechukwu… - Turkish Journal of …, 2022 - ncbi.nlm.nih.gov
Objectives: Vaccines are anticipated to control the ongoing coronavirus disease-2019
(COVID-19) pandemic, however, their acceptance is critical for the desired benefit. This …
(COVID-19) pandemic, however, their acceptance is critical for the desired benefit. This …
[HTML][HTML] Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26. COV2. S and ChAdOx1 adenoviral vector COVID-19 …
CO Iheanacho, UIH Eze - Future Journal of Pharmaceutical Sciences, 2022 - Springer
Abstract Background Vaccination against Coronavirus disease 2019 (COVID-19) is an
important means of controlling the pandemic, however they are expected to stimulate …
important means of controlling the pandemic, however they are expected to stimulate …
[PDF][PDF] Что известно о влиянии артериальной гипертензии на течение COVID-19
МВ Моисеева, НВ Багишева, АВ Мордык… - … разбор в общей …, 2022 - klin-razbor.ru
Аннотация Целью настоящей работы была попытка систематизации имеющихся в
доступной литературе данных о течении коронавирусной инфекции (COVID-19) у …
доступной литературе данных о течении коронавирусной инфекции (COVID-19) у …
[HTML][HTML] THE IMPACT OF HYPERTENSION ON COVID-19 SEVERITY: A GLOBAL REVIEW
S Manvendra - Вестник Ошского государственного университета …, 2023 - cyberleninka.ru
Hypertension, also known as high blood pressure, is a prevalent medical condition that can
exacerbate the severity of coronavirus disease 2019 (COVID-19). Studies from around the …
exacerbate the severity of coronavirus disease 2019 (COVID-19). Studies from around the …
[HTML][HTML] COVID-19 and RAAS inhibitors: is there a final conclusion?
M Talebi-Taher, MH Najafi, S Behzad - Iranian Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), the first pandemic caused by a human
infecting coronavirus, has drawn global attention from the first time it appeared in Wuhan city …
infecting coronavirus, has drawn global attention from the first time it appeared in Wuhan city …
[PDF][PDF] 新規レニン阻害薬TAK-272 の抗心不全効果の検討およびヒトレニン阻害薬に最適化したマウス心不全モデルの開発
原智也， ハラトモヤ - 2022 - tsukuba.repo.nii.ac.jp
ARNI: Angiotensin receptor neprilysin inhibitor ANP: Atrial natriuretic peptide ARB:
アンジオテンシン II 受容体拮抗剤 ARDS: 急性呼吸促迫症候群 AT1 受容体: I …
アンジオテンシン II 受容体拮抗剤 ARDS: 急性呼吸促迫症候群 AT1 受容体: I …